Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes
- 22 Dec 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 23 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.